His and Her Health

  • Increase font size
  • Default font size
  • Decrease font size
Message
  • Your account has been created and an activation link has been sent to the e-mail address you entered. Note that you must activate the account by clicking on the activation link when you get the e-mail before you can login.
Frontpage Slideshow | Copyright © 2006-2010 JoomlaWorks, a business unit of Nuevvo Webware Ltd.

Report: No Mortality Benefit with Routine PSA Screening, Longer-Term Follow-Up Shows

According to a report in the Jan. 9, 2012, “Journal Watch,” screening with prostate-specific antigen (PSA) testing does not lower the risk for death from prostate cancer, according to a 13- year follow-up report from the PLCO trial. The abstract for the follow up report was published in the Journal of the National Cancer Institute. This finding extends the trial's 10-year results, which similarly showed no mortality benefit. “Journal Watch” noted that the PLCO trial, some 77,000 men aged 55 to 74 were either randomly placed in 6 years of PSA testing plus 4 years of digital rectal examinations, or to usual care (which could include opportunistic screening). “At 13 years' follow-up, there was no difference between the groups in prostate cancer mortality. The incidence of prostate cancer, however, was significantly higher with screening than with usual care (108.4 vs. 97.1 per 10,000 person-years),” “Journal Watch” reported. The researchers conclude: "There is no evidence of a benefit [from screening]. Indeed, there is evidence of harms, in part associated with the false-positive tests, but also with the over diagnosis inseparable from PSA screening."

[Report] Advises Against Routine Prostate Cancer Screening

Last Updated on Thursday, 12 January 2012 12:59
 

Prostate Cancer: by EmpowerHER.com

Prostate Cancer (Cancer of the Prostate; Prostatic Carcinoma) by Krisha McCoy, MS Definition Prostate cancer is a disease in which cancer cells grow in the prostate gland. The prostate is a walnut-sized gland in men. It surrounds the urethra. The prostate makes a fluid that is part of semen. This disease occurs in men.

To read the rest of this article from EmpowHER.com CLICK HERE

Last Updated on Thursday, 29 September 2011 07:48
 

Prostate Cancer

Here you will find the latest news on Prostate Cancer treatments and information.

Every September we celebrate Prostate Awareness Month by dedicating a section of our site to providing the most recent information surrounding Prostate Cancer research.

 

Seniors: Sex, Health, and Good Years

There's a report in the British Medical Journal on sex and aging and health.  There were some genuine surprises, but the bottom line is that middle- and older-age men and women who perceive themselves to be in very good health are more likely to be sexually active. Researchers analyzed interview data from two nationally representative samples of some 6000 U.S. adults aged 25 through 85.

Last Updated on Thursday, 25 August 2011 12:15 Read more...
 

What the JAMA Estrogen Only Study Means To You

A study in the Journal of the American Medical Association (JAMA, April 6,2011)) sheds new light on taking estrogen. Here is what it means to you.

Estrogen versus Estrogen and Progesterone and Uterine Cancer

Like all medications, estrogen is a powerful hormone with benefits and risks that have to be weighed and personalized for each woman. Forty years ago estrogen was so popular and considered so beneficial that almost all women were encouraged to take it from the time of menopause until death. Unfortunately, it was found that estrogen alone can cause cancer of the uterus. Women who have had a hysterectomy and had their uterus removed don’t have this problem.

Then researchers discovered that women who take daily estrogen combined with progesterone for at least 10 days of the month did not get uterine cancer. There were some risks of blood clots and strokes, but overall it was believed that estrogen plus progesterone protected the uterus from uterine cancer and estrogen helped to prevent heart disease. The heart disease part of this changed with more research.

Read More

Last Updated on Friday, 22 April 2011 08:44
 

Author, Educator Dr. Michael Krychman Joins www.Ourgyn.com as site’s Co-Director

Dr. Michael Krychman, a gynecologist, clinical sexologist and AASECT-certified sexual counselor with a Masters in Public Health and Human Sexuality, has joined Dr. Andrew Goldstein as Co-Director of www.ourgyn.com, a Vibrance Associates site. His articles and special videos will appear here as well as our other award-winning sites in the Vibrance Network along with those of Dr. Goldstein.

To read more click HERE

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  Next 
  •  End 
  • »


Page 1 of 4